Literature DB >> 29134230

Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway.

Salvatore Chirumbolo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29134230     DOI： 10.1007/s00011-017-1111-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  20 in total

1.  Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway.

Authors:  Varvara Nikolaidou-Neokosmidou; Vassilis I Zannis; Dimitris Kardassis
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

2.  Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro.

Authors:  Jing-yao Pang; Kui-jun Zhao; Jia-bo Wang; Zhi-jie Ma; Xiao-he Xiao
Journal:  J Zhejiang Univ Sci B       Date:  2014-06       Impact factor: 3.066

3.  Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.

Authors:  Hai Huang; Wei Zhou; Haiyan Zhu; Pei Zhou; Xunlong Shi
Journal:  Toxicol Appl Pharmacol       Date:  2017-03-18       Impact factor: 4.219

4.  Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.

Authors:  Wei He; Li-Xia Li; Qing-Jiao Liao; Chun-Lan Liu; Xu-Lin Chen
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

5.  Anti-hepatitis B virus activity of wogonin in vitro and in vivo.

Authors:  Qinglong Guo; Li Zhao; Qidong You; Yong Yang; Hongyan Gu; Guoliang Song; Na Lu; Jian Xin
Journal:  Antiviral Res       Date:  2007-01-24       Impact factor: 5.970

6.  Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line.

Authors:  Nobuo Nakamura; Seiji Hayasaka; Xue-Yun Zhang; Yasunori Nagaki; Masayuki Matsumoto; Yoriko Hayasaka; Katsutoshi Terasawa
Journal:  Exp Eye Res       Date:  2003-08       Impact factor: 3.467

7.  Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.

Authors:  D Altavilla; F Squadrito; A Bitto; F Polito; B P Burnett; V Di Stefano; L Minutoli
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

8.  Flavocoxid exerts a potent antiviral effect against hepatitis B virus.

Authors:  Teresa Pollicino; Cristina Musolino; Natasha Irrera; Alessandra Bitto; Daniele Lombardo; Martina Timmoneri; Letteria Minutoli; Giovanni Raimondo; Giovanni Squadrito; Francesco Squadrito; Domenica Altavilla
Journal:  Inflamm Res       Date:  2017-10-10       Impact factor: 4.575

9.  Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection.

Authors:  Ying Ju; Nan Hou; Xiao Ning Zhang; Di Zhao; Ying Liu; Jin Jin Wang; Fang Luan; Wei Shi; Fa Liang Zhu; Wen Sheng Sun; Li Ning Zhang; Cheng Jiang Gao; Li Fen Gao; Xiao Hong Liang; Chun Hong Ma
Journal:  Cell Mol Immunol       Date:  2009-02       Impact factor: 11.530

10.  IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.

Authors:  Gianna Aurora Palumbo; Cecilia Scisciani; Natalia Pediconi; Leonardo Lupacchini; Dulce Alfalate; Francesca Guerrieri; Ludovica Calvo; Debora Salerno; Silvia Di Cocco; Massimo Levrero; Laura Belloni
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240
View more
  2 in total

Review 1.  Antiviral Properties of Baicalin: a Concise Review.

Authors:  Kunwei Li; Yiyu Liang; Ao Cheng; Qi Wang; Ying Li; Haocheng Wei; Changzheng Zhou; Xinhuan Wan
Journal:  Rev Bras Farmacogn       Date:  2021-10-06       Impact factor: 2.010

2.  Dual effects of baicalin on osteoclast differentiation and bone resorption.

Authors:  Xuanyuan Lu; Wei He; Wanlei Yang; Jianlei Li; Weiqi Han; Qian Liu; Tan Zhang; Jiawei Jiang; An Qin; Yu Qian
Journal:  J Cell Mol Med       Date:  2018-07-16       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.